Alibaba Health Information Stock Fundamentals

ALBHF Stock  USD 0.48  0.07  17.07%   
Alibaba Health Information fundamentals help investors to digest information that contributes to Alibaba Health's financial success or failures. It also enables traders to predict the movement of Alibaba Pink Sheet. The fundamental analysis module provides a way to measure Alibaba Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alibaba Health pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Alibaba Health Information Company Current Valuation Analysis

Alibaba Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Alibaba Health Current Valuation

    
  14.83 B  
Most of Alibaba Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alibaba Health Information is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Alibaba Health Information has a Current Valuation of 14.83 B. This is 3.26% higher than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The current valuation for all United States stocks is 10.78% higher than that of the company.

Alibaba Health Infor Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alibaba Health's current stock value. Our valuation model uses many indicators to compare Alibaba Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alibaba Health competition to find correlations between indicators driving Alibaba Health's intrinsic value. More Info.
Alibaba Health Information is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alibaba Health's earnings, one of the primary drivers of an investment's value.

Alibaba Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alibaba Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Alibaba Health could also be used in its relative valuation, which is a method of valuing Alibaba Health by comparing valuation metrics of similar companies.
Alibaba Health is currently under evaluation in current valuation category among its peers.

Alibaba Fundamentals

About Alibaba Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Alibaba Health Information's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alibaba Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alibaba Health Information based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. Alibaba Health Information Technology Limited is based in Causeway Bay, Hong Kong. Alibaba Health operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 1849 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Alibaba Pink Sheet

Alibaba Health financial ratios help investors to determine whether Alibaba Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alibaba with respect to the benefits of owning Alibaba Health security.